Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01618045 · ClinicalTrials.gov registry record

Nutritional Regulation of Wound Inflammation: Part II

A clinical trial, sponsored by Ohio State University.

Completed
Registry status
24
Enrollment target

NCT01618045 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01618045 has completed, sponsored by Ohio State University.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

Fermented Papaya Preparation (FPP) is a sweet and granular substance available over the counter. FPP possesses antioxidant properties, which provide benefit against age-related complications, and is also known to protect red blood cells (RBCs) against oxidative damage and to help protect against severe forms of thalassemia. The investigators recently showed that ex vivo supplementation of FPP can correct respiratory burst performance of diabetic peripheral blood mononuclear cells (PBMC) via a Sp-1 dependant pathway. Based on these observations, the investigators propose to study the outcome that FPP supplementation has in patients with diabetes.

Interventions

  • DIETARY_SUPPLEMENT Fermented Papaya Preparation (FPP)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-05
Est. Completion 2015-02-19

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT01618045

The ClinicalTrials.gov registry entry for NCT01618045 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Fermented Papaya Preparation (FPP) is the first listed.

NCT01618045 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01618045 about?

NCT01618045 is a clinical study titled "Nutritional Regulation of Wound Inflammation: Part II". Fermented Papaya Preparation (FPP) is a sweet and granular substance available over the counter. FPP possesses antioxidant properties, which provide benefit against age-related complications, and is also known to protect red blood cells (RBCs) against oxidative damage and to help protect against sev...

What is the current status of trial NCT01618045?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2012-05. Estimated completion is 2015-02-19.

What interventions are being tested in trial NCT01618045?

The interventions under investigation include: Fermented Papaya Preparation (FPP) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01618045?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.